Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking
Unfortunately, another phase-II/III clinical study for the treatment of autosomal dominant polycystic kidney disease was stopped because it failed to show clinical benefits to patients
Goldberg DM, Spooner RJ
Store credit will be offered but not guaranteed if stock has already been allocated to your order
It exists in almost every cell of the human body
US$ 23.06
US$ 21.74
US$ 25.88
US$ 23.42
